Table 4. Impact of intervention on prevalence of ICD-10 CMD at 6 months, by baseline diagnostic group and facility type (secondary analyses).
| Diagnostic group at baseline | Type of facility |
p-value for effect modification | ||
|---|---|---|---|---|
| All facilities | PHC | GPs | ||
| Screen positive cases (n=2429) | ||||
| Collaborative Stepped Care | 354 (28.8%) | 196 (27.7%) | 158 (29.9%) | |
| Enhanced Usual Care | 541 (38.6%) | 375 (50.8%) | 166 (29.4%) | |
| Risk difference (95% CI) | -9.9% (-19.4%, -0.03%) | -23.1% (-42.1%, -4.2%) | -0.05% (-12.9%, 14.0%) | <0.001 |
| Risk ratio (95% CI) | 0.76 (0.57–1.02) | 0.54 (0.37–0.81) | 1.07 (0.66–1.74) | 0.003 |
| P-value | 0.06 | 0.01 | 0.76 | |
|
| ||||
| Sub-threshold cases (n=468) | ||||
| Collaborative Stepped Care | 30 (12.7%) | 20 (12.4%) | 10 (13.0%) | |
| Enhanced Usual Care | 77 (25.0%) | 49 (31.2%) | 28 (19.9%) | |
| Risk difference (95% CI) | -12.3% (-23.5%, -1.1%) | -18.8% (-46.6%, 9.0%) | -6.9% (-19.3%, 5.5%) | 0.18 |
| Risk ratio (95% CI) | 0.52 (0.29–0.96) | 0.40 (0.11–1.38) | 0.70 (0.31–1.59) | 0.16 |
| P-value | 0.04 | 0.11 | 0.35 | |